Biomarkers have emerged as pivotal tools in the realm of clinical development, driving significant advancements in precision medicine. Their relevance lies in their ability to provide crucial insights into the molecular underpinnings of diseases, which facilitates the stratification of patients based on disease subtypes and predicted responses to therapies. This enables the design of more targeted and effective clinical trials, thereby accelerating the drug development process. Biomarkers also play a crucial role in early diagnosis, disease monitoring, and the assessment of treatment efficacy and safety, ensuring that therapeutic interventions are tailored to individual patient profiles. The integration of biomarkers into clinical development pipelines has not only enhanced our understanding of disease mechanisms but has also led to the identification of novel therapeutic targets. Challenges remain, including the need for rigorous validation and standardization of biomarkers, but the potential benefits underscore their critical importance. This chapter explores the multifaceted roles of biomarkers, providing a comprehensive overview of their contributions to clinical development and their impact on the future of personalized medicine. By elucidating the challenges and opportunities inherent in biomarker research, we aim to highlight their transformative potential in the pursuit of optimized healthcare outcomes.